BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27281989)

  • 21. Probing the cellular effects of bacterial effector proteins with the Yersinia toolbox.
    Wölke S; Heesemann J
    Future Microbiol; 2012 Apr; 7(4):449-56. PubMed ID: 22439722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crosstalk of signalling processes of innate immunity with Yersinia Yop effector functions.
    Ruckdeschel K; Deuretzbacher A; Haase R
    Immunobiology; 2008; 213(3-4):261-9. PubMed ID: 18406372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of Pyrin Dephosphorylation and Inflammasome Activation in Macrophages as Triggered by the
    Medici NP; Rashid M; Bliska JB
    Infect Immun; 2019 Mar; 87(3):. PubMed ID: 30602502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells.
    Cornelis GR; Wolf-Watz H
    Mol Microbiol; 1997 Mar; 23(5):861-7. PubMed ID: 9076724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical functions of Yersinia type III effectors.
    Shao F
    Curr Opin Microbiol; 2008 Feb; 11(1):21-9. PubMed ID: 18299249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coiled-coils in the YopD translocator family: a predicted structure unique to the YopD N-terminus contributes to full virulence of Yersinia pseudotuberculosis.
    Costa TR; Amer AA; Fällman M; Fahlgren A; Francis MS
    Infect Genet Evol; 2012 Dec; 12(8):1729-42. PubMed ID: 22910185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TyeA of Yersinia pseudotuberculosis is involved in regulation of Yop expression and is required for polarized translocation of Yop effectors.
    Sundberg L; Forsberg A
    Cell Microbiol; 2003 Mar; 5(3):187-202. PubMed ID: 12614462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yersinia pseudotuberculosis YopD mutants that genetically separate effector protein translocation from host membrane disruption.
    Adams W; Morgan J; Kwuan L; Auerbuch V
    Mol Microbiol; 2015 May; 96(4):764-78. PubMed ID: 25684661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gain-of-Function Analysis Reveals Important Virulence Roles for the Yersinia pestis Type III Secretion System Effectors YopJ, YopT, and YpkA.
    Palace SG; Proulx MK; Szabady RL; Goguen JD
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29891548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro association between the virulence proteins, YopD and YopE, of Yersinia enterocolitica.
    Hartland EL; Robins-Browne RM
    FEMS Microbiol Lett; 1998 May; 162(2):207-13. PubMed ID: 9627954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting exported substrates to the Yersinia TTSS: different functions for different signals?
    Lloyd SA; Forsberg A; Wolf-Watz H; Francis MS
    Trends Microbiol; 2001 Aug; 9(8):367-71. PubMed ID: 11514218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not required for virulence in a rat model of bubonic plague.
    Lemaître N; Sebbane F; Long D; Hinnebusch BJ
    Infect Immun; 2006 Sep; 74(9):5126-31. PubMed ID: 16926404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell death programs in Yersinia immunity and pathogenesis.
    Philip NH; Brodsky IE
    Front Cell Infect Microbiol; 2012; 2():149. PubMed ID: 23226685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disabling surveillance: bacterial type III secretion system effectors that suppress innate immunity.
    Espinosa A; Alfano JR
    Cell Microbiol; 2004 Nov; 6(11):1027-40. PubMed ID: 15469432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effector functions of pathogenic Yersinia species.
    Aepfelbacher M; Trasak C; Ruckdeschel K
    Thromb Haemost; 2007 Sep; 98(3):521-9. PubMed ID: 17849040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The
    Schubert KA; Xu Y; Shao F; Auerbuch V
    Annu Rev Microbiol; 2020 Sep; 74():221-245. PubMed ID: 32660389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular determinants of Yersinia pathogenesis.
    Iriarte M; Cornelis GR
    Microbiologia; 1996 Jun; 12(2):267-80. PubMed ID: 8767710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of Yersinia Yop-effector delivery by translocated YopE.
    Aili M; Isaksson EL; Carlsson SE; Wolf-Watz H; Rosqvist R; Francis MS
    Int J Med Microbiol; 2008 Apr; 298(3-4):183-92. PubMed ID: 17597003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virulence markers of LCR plasmid in Indian isolates of Yersinia pestis.
    Khushiramani R; Tuteja U; Shukla J; Panikkar A; Batra HV
    APMIS; 2006 Jan; 114(1):15-22. PubMed ID: 16499656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of MAPK and NF-kappa B pathways is necessary for rapid apoptosis in macrophages infected with Yersinia.
    Zhang Y; Ting AT; Marcu KB; Bliska JB
    J Immunol; 2005 Jun; 174(12):7939-49. PubMed ID: 15944300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.